We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

26 hedge funds and large institutions have $5.49M invested in Microbot Medical in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

0.34% more ownership

Funds ownership: 10.62% → 10.96% (+0.34%)

8% less capital invested

Capital invested by funds: $6M → $5.49M (-$502K)

10% less funds holding

Funds holding: 29 → 26 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
26
Holders Change
-3
Holders Change %
-10.34%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$302K
2
BlackRock
BlackRock
New York
+$118K
3
Morgan Stanley
Morgan Stanley
New York
+$116K
4
Bank of America
Bank of America
North Carolina
+$9.5K
5
SIAP
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
+$7.25K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$318K
2
Citadel Advisors
Citadel Advisors
Florida
-$81K
3
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$8K
4
UBS Group
UBS Group
Switzerland
-$3.88K
5
JP Morgan Chase
JP Morgan Chase
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.9M – – –
BlackRock
2
BlackRock
New York
$1.09M +$118K +16,205 +12%
AA
3
AlphaCentric Advisors
Puerto Rico
$703K – – –
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$668K +$302K +41,686 +78%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$355K – – –
State Street
6
State Street
Massachusetts
$244K +$2.17K +300 +0.9%
Morgan Stanley
7
Morgan Stanley
New York
$137K +$116K +15,934 +455%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$110K – – –
Northern Trust
9
Northern Trust
Illinois
$84K – – –
SPIA
10
Steward Partners Investment Advisory
New York
$82K – – –
IMA
11
Investment Management Associates
Colorado
$70K – – –
SIAP
12
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$24K +$7.25K +1,000 New
Bank of America
13
Bank of America
North Carolina
$9K +$9.5K +1,310 +1,955%
Wells Fargo
14
Wells Fargo
California
$8K -$15 -2 -0.2%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$4K – – –
Osaic Holdings
16
Osaic Holdings
Arizona
$1K -$73 -10 -5%
PFGIA
17
Patriot Financial Group Insurance Agency
Massachusetts
$1K – – –
RE
18
RBC Europe
United Kingdom
$7 – – –
Renaissance Technologies
19
Renaissance Technologies
New York
– -$318K -40,113 Closed
Citadel Advisors
20
Citadel Advisors
Florida
– -$81K -10,194 Closed
PNC Financial Services Group
21
PNC Financial Services Group
Pennsylvania
– -$8K -1,000 Closed
UBS Group
22
UBS Group
Switzerland
– -$3.88K -535 -100%
JP Morgan Chase
23
JP Morgan Chase
New York
– -$3K -418 Closed
HI
24
Harbour Investments
Wisconsin
– -$7 -1 -50%
Fidelity Investments
25
Fidelity Investments
Massachusetts
– +$36 +5 +500%

MBOT Hedge Fund Activity: Q3 2021 in Review

26 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2021, worth a combined $5.49M — down 8.4% from $6M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of MBOT and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 6 added.

The largest buyer was Dimensional Fund Advisors, adding an estimated $302K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $318K sold.

  • 26 institutional investors held Microbot Medical (MBOT) as of Q3 2021, down from 29 in Q2 2021.
  • Funds reported $5.49M of Microbot Medical stock for Q3 2021, down 8.4% quarter-over-quarter.
  • 1 fund opened new Microbot Medical positions in Q3 2021 and 4 closed out, a net change of -3 holders.
  • The largest Microbot Medical buyer in Q3 2021 was Dimensional Fund Advisors, an estimated $302K added.
  • The largest Microbot Medical seller in Q3 2021 was Renaissance Technologies, an estimated $318K sold.

Based on aggregated 13F filings for Q3 2021.